An overview of topical photodynamic therapy in dermatology

Photodiagnosis and Photodynamic Therapy

Volumn 7, Issue 1, 2010, Pages 16-23

  Ibbotson, Sally H ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

ALA; Cancer; MAL; Photodynamic therapy; Skin; Topical

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; FLUOROURACIL; IMIQUIMOD; PHOTOSENSITIZING AGENT;

ACTINIC KERATOSIS; ANALGESIA; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER SURGERY; CRYOTHERAPY; FLUORESCENCE; GRAFT RECIPIENT; HUMAN; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PAIN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; SKIN DISEASE; SQUAMOUS CELL CARCINOMA; TREATMENT INDICATION;

DERMATOLOGY; HUMANS; PHOTOCHEMOTHERAPY; SKIN DISEASES;

EID: 77949262252     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2009.12.001     Document Type: Article

References (93)

1. Kennedy J.C., Pottier R.H., and Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B Biol 6 (1990) 143-148
2. Svanberg K., Andersson T., Killander D., et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical δ-aminolevulinic acid sensitization and laser irradiation. Br J Dermatol 130 (1994) 743-751
3. Smits T., van Laarhoven A.I.M., Staassen A., et al. Induction of protoporphyrin IX by aminolaevulinic acid in actinic keratosis, psoriasis and normal skin: preferential porphyrin enrichment in differentiated cells. Br J Dermatol 160 (2009) 849-857
4. Soler A.-M., Angell-Petersen E., Warloe T., et al. Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources. Photochem Photobiol 71 (2000) 724-729
5. Clark C., Bryden A., Dawe R.S., et al. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmmunol Photomed 19 (2003) 134-141
6. Moseley H., Allen J.W., Ibbotson S.H., et al. Ambulatory photodynamic therapy: a new concept in delivering photodynamic therapy. Br J Dermatol 154 (2006) 747-750
7. Attili S.K., Lesar A., McNeill A., et al. An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer. Br J Dermatol 161 (2009) 170-173
8. Babilas P., Knobler R., Hummel S., et al. Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial. Br J Dermatol 157 (2007) 111-117
9. Wiegell S.R., Haedersdal P.A., Philipsen P.A., et al. Continuous activation of PpIX by daylight is as effective and less painful than conventional photodynamic therapy for actinic keratoses: a randomized, controlled, single blinded study. Br J Dermatol 158 (2008) 740-746
10. Wiegell S.R., Haedersdal, Eriksen P., et al. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double blinded randomized clinical trial. Br J Dermatol 160 (2009) 1308-1314
11. Morton C., Brown S.B., Collins S., et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 146 (2002) 552-567
12. Morton C.A., McKenna K.E., Rhodes L.E., et al. Guidelines for topical photodynamic therapy: update. Br J Dermatol 159 (2008) 1245-1266
13. Braathen L.R., Szeimies R.-M., Basset-Seguin N., et al. Guidelines on the use of photodynamic therapy for non-melanoma skin cancer: an international consensus. J Am Acad Dermatol 56 (2007) 125-143
14. Calzavara-Pinton P.G. Repetitive photodynamic therapy with topical δ-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumors. J Photochem Photobiol B-Biol 29 (1995) 53-57
15. Tschen E.H., Wong D.S., Pariser D.M., et al. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Br J Dermatol 155 (2006) 1262-1269
16. Tarstedt M., Rosdahl I., Berne B., et al. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm Venereol 85 (2005) 424-428
17. Braathen L.R., Paredes B.E., Salsela O., et al. Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses. J Euro Acad Dermatol 23 (2009) 550-555
18. Szeimies R.M., Karrer S., Radakovic-Fijan S., et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 47 (2002) 258-262
19. Freeman M., Vinciullo C., Francis D., et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective randomized study. J Dermatol Treat 14 (2003) 99-106
20. Morton C., Campbell S., Gupta G., et al. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol 155 (2006) 1029-1036
21. Kurwa H.A., YoNg-Gee S.A., Seed P.T., et al. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol 41 (1999) 414-418
22. Smith S., Piacquadio D., Morhenn V., et al. Short incubation PDT versus 5-FU in treating actinic keratoses. J Drugs Dermatol 2 (2003) 629-635
23. Sotiriou E., Apalla Z., Maliamani F., et al. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities. J Euro Acad Dermatol 23 (2009) 1061-1065
24. Cox N.H., Eedy D.J., and Morton C.A. Guidelines for management of Bowen's disease: 2006 update. Br J Dermatol 156 (2007) 11-21
25. Graham J.H., Elson B., and Helwig M.D. Bowen's disease and its relationship to systemic cancer. Arch Dermatol 83 (1961) 738-758
26. Thestrup-Pedersen K., Ravnborg L., and Reymann F. Morbus bowen - a description of the disease in 617 patients. Acta Derm Venereol 68 (1988) 236-239
27. Cox N.H., Eedy D.J., and Morton C.A. Guidelines for management of Bowen's disease. Br J Dermatol 141 (1999) 633-641
28. Lehmann P. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol 156 (2007) 793-801
29. Stables G.I., Stringer M.R., Robinson D.J., et al. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol 136 (1997) 957-960
30. Morton C.A., Whitehurst C., McColl J.H., et al. Photodynamic therapy for large or multiple patches of Bowen's disease and basal cell carcinoma. Arch Dermatol 137 (2001) 319-324
31. Togsverd-Bo K., Haedersdal M., and Wulf H.C. Photodynamic therapy for tumors on the eyelid margins. Arch Dermatol 145 (2009) 944-947
32. Morton C.A., Whitehurst C., Moseley H., et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 135 (1996) 766-771
33. Salim A., Leman J.A., McColl J.H., et al. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 148 (2003) 539-543
34. Morton C., Horn M., Leman J., et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial. Arch Dermatol 142 (2006) 729-735
35. Wang I., Bendsoe N., Klinteberg C.A.F., et al. Photodynamic therapy vs. cryotherapy of basal cell carcinoma: results of a phase III clinical trial. Br J Dermatol 144 (2001) 832-840
36. Basset-Seguin N., Ibbotson S.H., Emtestam L., et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Euro J Dermatol 18 (2008) 547-553
37. Szeimies R.M., Ibbotson S.H., Murrell D.F., et al. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol 22 (2008) 1302-1311
38. Rhodes L.E., de Rie M.A., Leifsdottir, et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol 143 (2007) 1131-1136
39. Berroeta L., Clark C., Dawe R.S., et al. A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma. Br J Dermatol 157 (2007) 401-403
40. Mosterd K., Thissen M.R.T.M., Nelemans P., et al. Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial. Br J Dermatol 159 (2008) 864-870
41. Morton C., MacKie R.M., Whitehurst C., et al. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol 134 (1998) 248-249
42. Soler A.M., Warloe T., Tausjo J., et al. Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. Acta Derm Venereol 79 (1999) 204-206
43. Soler A.M., Warloe T., Berner A., et al. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 145 (2001) 467-471
44. Thissen M.R.T.M., Schroeter C.A., and Neumann H.A.M. Photodynamic therapy with delta-aminolaevulinic for nodular basal cell carcinoma using a prior debulking technique. Br J Dermatol 142 (2000) 338-339
45. De Haas E.R.M., De Bruijn H.S., Sterenborg H.J.C.M., et al. Microscopic distribution of protoporphyrin IX (PpIX) fluorescence in superficial basal cell carcinoma during light-fractionated aminolaevulinic acid photodynamic therapy. Acta Derm Venereol 88 (2008) 547-554
46. De Haas E.R.M., de Vijlder H.C., Sterenborg H.J.C.M., et al. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer. J Euro Acad Dermatol 22 (2008) 426-430
47. Campbell S.M., Morton C.A., Alyahya R., et al. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma. Br J Dermatol 159 (2008) 387-393
48. Gerritsen M.J., Smits T., Kleinpenning M.M., et al. Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy. Dermatology 218 (2009) 193-202
49. Dragieva G., Prinz B.M., Hafner J., et al. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol 151 (2004) 196-200
50. Piaserico S., Fortina A.B., Rigotti P., et al. Topical photodynamic therapy of actinic keratosis in renal transplant recipients. Transplantation Proc 39 (2007) 1847-1850
51. Wulf H.C., Pavel S., Stender I., et al. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol 86 (2006) 25-28
52. De Graaf Y.G.L., Kennedy C., Wolterbeek R., et al. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. J Invest Dermatol 126 (2006) 569-574
53. Wennberg A.-M., Stenquist B., Stockfleth E., et al. Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study. Transplantation 86 (2008) 423-429
54. Perrett C.M., McGregor J.M., Warwick J., et al. Treatment of post-transplantation premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br J Dermatol 156 (2007) 320-328
55. Rud E., Gederaas O., Høgset A., et al. 5-aminolevulinic acid, but not 5-aminolevulinic esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol 71 (2000) 640-647
56. Brooke R.C.C., Sinha A., Sidhu M.K., et al. Histamine is released following aminolevulinic acid-photodynamic therapy of human skin and mediates an aminolevulinic acid dose-related immediate inflammatory response. J Invest Dermatol 126 (2006) 2296-2301
57. Ericson M.B., Sandberg C., Stenquist B., et al. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol 151 (2004) 1204-1212
58. Grapengiesser S., Gudmundsson O., Larko O., et al. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 27 (2002) 493-497
59. Sandberg C., Stenquist B., Rosdal I., et al. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm-Venereol 86 (2006) 404-408
60. Wiegell S.R., Stender I.-M., Renhua N.A., et al. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. Arch Dermatol 139 (2003) 1173-1177
61. Wiegell S.R., Skiveren J., Philipsen P.A., et al. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol 158 (2008) 727-733
62. Wiegell S.R., and Wulf H.C. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. J Am Acad Dermatol 54 (2006) 647-651
63. Kasche A., Luderschmidt S., Ring J., et al. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. J Drugs Dermatol 5 (2006) 353-356
64. Kuijpers D.I., Thissen M.R., Thissen C.A., et al. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma. J Drugs Dermatol 5 (2006) 642-645
65. Moloney F.J., and Collins P. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratoses. Br J Dermatol 157 (2007) 87-91
66. Schleier P., Berndt A., Kolossa S., et al. Comparison of aminolevulinic acid (ALA)-thermogel-PDT with methyl-ALA-thermogel-PDT in basal cell carcinoma. Photodiagnosis Photodyn Ther 4 (2007) 197-201
67. Horfelt C., Funk J., Frohm-Nilsson M., et al. Topical methyl aminolaevulinate photodynamic therapy for treatment of facial acne vulgaris: results of a randomized, controlled study. Br J Dermatol 155 (2006) 608-613
68. Babilas P., Kohl E., Maisch T., et al. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Br J Dermatol 154 (2006) 712-718
69. Babilas P., Travnick R., Werner A., et al. Split-face study using two different light sources for topical PDT of actinic keratoses: non-inferiority of the LED system. J Dtsch Dermatol Gest 6 (2008) 25-32
70. Fritsch C., Stege H., Saalmann G., et al. Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses. Photodermatol Photoimmunol Photomed 13 (1997) 181-185
71. Morton C.A., Whitehurst C., Moore J.V., et al. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol 143 (2000) 767-772
72. Radakovic-Fijan S., Belcha-Thalhammer U., Kittler H., et al. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study. J Am Acad Dermatol 53 (2005) 823-827
73. Langmack K., Mehta R., Twyman P., et al. Topical photodynamic therapy at low fluence rates - theory and practice. J Photochem Photobiol B Biol 60 (2001) 37-43
74. Cottrell W.J., Paquette A.D., Keymel K.R., et al. Irradiance-dependent photobleaching and pain in δ-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas. Clin Cancer Res 14 (2008) 4475-4483
75. Wiegell S.R., Haedersdal M., and Wulf H.C. Cold water and pauses in illumination reduces pain during photodynamic therapy: a randomized clinical study. Acta Derm Venereol 89 (2009) 145-149
76. Pagliaro J., Elliot T., Bulsara M., et al. Cold air analgesia in photodynamic therapy of basal cell carcinomas as Bowen's disease: an effective addition to treatment. A pilot study. Dermatol Surg 30 (2004) 63-66
77. ®) for pain relief during topical photodynamic therapy. Br J Dermatol 150 (2004) 337-340
78. Langan S.M., and Collins P. Randomized, double-blind, placebo-controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2.5% and prilocaine 2.5% for topical 5-aminolaevulinic acid-photodynamic therapy for extensive scalp actinic keratoses. Br J Dermatol 154 (2006) 146-149
79. Skiveren J., Haedersdal M., Philipsen P.A., et al. Morphine gel 0.3% does not relieve pain during photodynamic therapy: a randomized, double-blind, placebo-controlled study. Acta Derm Venereol 86 (2006) 409-411
80. Halldin C.B., Paoli J., Sandberg C., et al. Transcutaneous electrical nerve stimulation for pain relief during photodynamic therapy. Acta Derm Venereol 88 (2008) 311-313
81. Borelli C., Herzinger T., Merk K., et al. Effect of cutaneous infiltration anaesthesia on pain in photodynamic therapy: a controlled open pilot trial. Dermatol Surg 33 (2007) 314-318
82. Paoli J., Halldin C., Ericson M.B., et al. Nerve blocks provide effective pain relief during photodynamic therapy for extensive facial actinic keratoses. Clin Exp Dermatol 33 (2008) 559-564
83. Halldin C.B., Paoli J., Sandberg C., et al. Nerve blocks enable adequate pain relief during topical photodynamic therapy of field cancerization on the forehead and scalp. Br J Dermatol 160 (2009) 795-800
84. Fritsch C., and Ruzicka T. Fluorescence diagnosis and photodynamic therapy in dermatology from experimental state to clinic standard methods. J Environ Pathol Toxicol Oncol 25 (2006) 425-440
85. Ibbotson S.H. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. Br J Dermatol 146 (2002) 178-188
86. Taylor M.N., and Gonzalez M.L. The practicalities of photodynamic therapy in acne vulgaris. Br J Dermatol 160 (2009) 1140-1148
87. Horfelt C., Stenquist B., Halldin C.B., et al. Single low-dose red light is as efficacious as methyl-aminolevulinate-photodynamic therapy for treatment of acne: clinical assessment and fluorescence monitoring. Acta Derm Venereol 89 (2009) 372-378
88. Haedersdal M., Togsverd-Bo K., Wiegell S.R., et al. Long-pulsed dye laser versus laser-assisted photodynamic therapy for acne vulgaris: a randomized controlled trial. J Am Acad Dermatol 58 (2008) 387-394
89. Haedersdal M., Togsverd-Bo K., and Wulf H.C. Evidence-based review of lasers, light sources and photodynamic therapy in the treatment of acne vulgaris. J Eur Acad Derm Venereol 22 (2008) 267-278
90. Fauteck J.-D., Ackermann G., Birkel M., et al. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses. Arch Dermatol Res 300 (2008) 53-60
91. Zawislak A., Donnelly R.F., McCluggage W.G., et al. Clinical and immunohistochemical assessment of vulval intraepithelial neoplasia following photodynamic therapy using a novel bioadhesive patch-type system loaded with 5-aminolevulinic acid. Photodiag Photodynam Ther 6 (2009) 28-40
92. Donnelly R.F., McCarron P.A., AL-Kassas R., et al. Influence of formulation factors in PpIX production and photodynamic action of novel ALA-loaded microparticles. Biopharm Drug Dispos 30 (2009) 55-70
93. Donnelly R.F., Morrow D.I., MCarron P.A., et al. Microneedle arrays permit enhanced intradermal delivery of a performed photosensitizer. Photochem Photobiol 85 (2009) 195-204